TTOO Financial Statements From 2010 to 2025
| TTOO Stock | USD 0.01 0 9.09% |
Check T2 Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among T2 Biosystems' main balance sheet or income statement drivers, such as , as well as many indicators such as . TTOO financial statements analysis is a perfect complement when working with T2 Biosystems Valuation or Volatility modules.
TTOO |
T2 Biosystems Company Return On Equity Analysis
T2 Biosystems' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current T2 Biosystems Return On Equity | -6.22 |
Most of T2 Biosystems' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, T2 Biosystems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, T2 Biosystems has a Return On Equity of -6.2214. This is 74.05% lower than that of the Biotechnology sector and 6.87% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
T2 Biosystems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining T2 Biosystems's current stock value. Our valuation model uses many indicators to compare T2 Biosystems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across T2 Biosystems competition to find correlations between indicators driving T2 Biosystems's intrinsic value. More Info.T2 Biosystems is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value T2 Biosystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for T2 Biosystems' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About T2 Biosystems Financial Statements
T2 Biosystems investors utilize fundamental indicators, such as revenue or net income, to predict how TTOO Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. T2 Biosystems operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.
Pair Trading with T2 Biosystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if T2 Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Biosystems will appreciate offsetting losses from the drop in the long position's value.Moving against TTOO Pink Sheet
| 0.56 | SMFG | Sumitomo Mitsui Financial | PairCorr |
| 0.55 | MFG | Mizuho Financial | PairCorr |
| 0.52 | HD | Home Depot | PairCorr |
| 0.48 | MUFG | Mitsubishi UFJ Financial | PairCorr |
| 0.46 | SMFNF | Sumitomo Mitsui Financial | PairCorr |
The ability to find closely correlated positions to T2 Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace T2 Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back T2 Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling T2 Biosystems to buy it.
The correlation of T2 Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as T2 Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if T2 Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for T2 Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in TTOO Pink Sheet
T2 Biosystems financial ratios help investors to determine whether TTOO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TTOO with respect to the benefits of owning T2 Biosystems security.